Temozolomide in the management of dopamine agonist-resistant prolactinomas. [electronic resource]
- Clinical endocrinology Jun 2012
- 877-86 p. digital
Publication Type: Case Reports; Journal Article; Review
1365-2265
10.1111/j.1365-2265.2012.04373.x doi
Adolescent Adult Dacarbazine--analogs & derivatives Dopamine Agonists--therapeutic use Drug Resistance, Neoplasm--drug effects Humans Male Prolactinoma--drug therapy Temozolomide